Dra.Terry

Médica Cirurgiã do Aparelho Digestivo e Coloproctologista

[Dra.Terry @SaudeDigestiva]

@apm_sp é ineficiência, descaso e desrespeito.

[Dra.Terry @SaudeDigestiva]

@apm_sp após 4 meses de desligamento associativo, continuam debitando indevidadmente a mensalidade de minha CC, mesmo após eu ter entrado em contato 3x para relatar o fato e pedir ressarcimento. Desrespeito ímpar, roubo.

[Dra.Terry @SaudeDigestiva]

Idoso demais para atuar na medicina? https://t.co/6rVbGq1iIT via @medscape

[Siew Ng @Siew_C_Ng]

How best to manage #IBD during the #COVID19 pandemic, you may ask. https://t.co/mMEZOzxdAX
Here’s are you need to know on
1. Impact of IBD drugs on covid outcomes
2. Impact of IBD drugs on vaccine response
Our knowledge is evolving !

[Dra.Terry @SaudeDigestiva]

Genital warts and inflammatory bowel diseases: Danish real-world evidence to assess patient-relevant outcomes

Paul McLellan,Julien Kirchgesner

First published: 23 March 2022

https://t.co/WyIcvUUspt

https://t.co/X4wHjjAZiP

[Dra.Terry @SaudeDigestiva]

Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study https://t.co/Cyu9qjLZUo

[Dra.Terry @SaudeDigestiva]

TDM IBD https://t.co/EWR1w4foqF

[Dra.Terry @SaudeDigestiva]

📣 new biomarkers and personalized medicine in IBD https://t.co/ZL8cSPQOKT

[Keith Siau @drkeithsiau]

Management of IBD during and after pregnancy #GITwitter #MedEd

(Courtesy of @UmaMahadevanIBD)
https://t.co/gOqD4Cmpfp

[Dra.Terry @SaudeDigestiva]

Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease

https://t.co/59BaQLJQA9

[Dra.Terry @SaudeDigestiva]

Very interesting: Newly Discovered Vascular Barrier in the Brain May Explain IBD-Related Anxiety, Depression
https://t.co/jrTMgBrE3s

[Dra.Terry @SaudeDigestiva]

https://t.co/l8RVwOMvVW

[Dra.Terry @SaudeDigestiva]

Procon https://t.co/sx5qwrnPa0

[Dra.Terry @SaudeDigestiva]

Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis

https://t.co/DpiSwVCzEO

[Flavio @Flaviostein]

Consenso latinoamericano acerca de indicadores de calidad en EII de PANCCO-GETECCU. Muy bueno trabajo!

[The Lancet Gastroenterology & Hepatology @LancetGastroHep]

On #WorldArthritisDay, revisit this review on comorbidities in inflammatory bowel disease: a call for action

https://t.co/oTC2Tv1mVU #IBD #UEGWeek #gitwitter

[Elliot Tapper @ebtapper]

Rifaximin strengthens gut barrier in patients with #cirrhosis: RCT

Take homes:
1⃣@VishCPatel /@DebbieShawcros1 combo is 🔥
2⃣Rif's effect on gut microbiota clearer now
3⃣Study is small, some baseline diffs. Larger trial needed #livertwitter https://t.co/ptTOAqHk13

[Crohnonlus @Crohnonlus]

#Calprotectin: from biomarker to biological function https://t.co/Fbh6152WiU

[Adam Steinlauf @Adams1002]

Great review on efficacy and safety of the use of dual biologic therapy by our own, Dr. Stephanie Gold!!

[Dra.Terry @SaudeDigestiva]

https://t.co/O7gLatEkhx Xeljanz effective for UC regardless of prior TNFi failure